Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Fosun International ( (HK:0656) ) is now available.
Fosun International, through its subsidiary Fosun Pharma Industrial, has entered into an agreement to acquire a controlling stake in Green Valley Technology. This acquisition involves purchasing an 8.6667% equity interest and subscribing to new capital, resulting in Fosun holding 53% of Green Valley’s enlarged equity. The transaction aims to solidify Fosun’s position in the healthcare sector, with implications for its market strategy and stakeholder interests.
The most recent analyst rating on (HK:0656) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on Fosun International stock, see the HK:0656 Stock Forecast page.
More about Fosun International
Fosun International is a multinational company with a diverse portfolio, primarily involved in the healthcare, tourism, and financial services industries. It operates through its subsidiaries, including Fosun Pharma, focusing on pharmaceutical and healthcare products.
YTD Price Performance: 7.74%
Average Trading Volume: 5,294,306
Technical Sentiment Signal: Sell
Current Market Cap: HK$39.67B
See more data about 0656 stock on TipRanks’ Stock Analysis page.